Switzerland
Sage Therapeutics (SAGE) Shares Fall Following Alzheimer's Drug Trial Failure
Sage Therapeutics (SAGE) reported a significant drop in its stock price, falling more than 30% in pre-market trading. It later stabilized at an 11% decline. Thi